Frailty is a predictor for worse outcomes in patients hospitalized with Clostridioides difficile infection

被引:2
|
作者
Chaar, Abdelkader [1 ]
Yoo, Jin Woo [1 ]
Nawaz, Ahmad [1 ]
Rizwan, Rabia [1 ]
Agha, Osama Qasim [1 ]
Feuerstadt, Paul
机构
[1] Yale Sch Med, New Haven, CT USA
来源
ANNALS OF GASTROENTEROLOGY | 2024年 / 37卷 / 04期
关键词
Clostridioides difficile; colitis; frailty; Hospital Frailty Risk Score;
D O I
10.20524/aog.2024.0898
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Frailty has major health implications for affected patients and is widely used in the perioperative risk assessment. The Hospital Frailty Risk Score (HFRS) is a validated score that utilizes administrative billing data to identify patients at higher risk because of frailty. We investigated the utility of the HFRS in patients with Clostridioides difficile infection (CDI) to determine whether they were at risk for worse outcomes and higher healthcare resource utilization. Methods Using the 2017 National Inpatient Sample, we identified all adults with a primary diagnosis of CDI. We classified patients into 2 groups: those who had an HFRS <5 (NonFrailCDI) and those with a score >= 5 (FrailCDI). We assessed differences in hospital outcomes and healthcare resource utilization based on frailty status. Results We identified 93,810 hospitalizations, of which 54,300 (57.88%) were FrailCDI. FrailCDI patients were at higher risk for fulminant CDI (odds ratio [OR] 1.9, 95% confidence interval [CI] 1.6-2.3), requiring colectomy (OR 4.1, 95%CI 1.5-11.2), and inpatient mortality (OR 4.5, 95%CI 2.8-7.1). Furthermore, FrailCDI patients had higher odds of requiring Intensive Care Unit admission (OR 13.7, 95%CI 6.3-29.9) or transfer to another facility on discharge (OR 2.2, 95%CI 2.0-2.4), and had longer hospital stays and higher total charges when compared with NonFrailCDI. Conclusions Frailty as defined by the HFRS is an independent factor for worse outcomes and higher healthcare utilization in adults admitted for CDI. Risk stratifying patients by frailty may improve outcomes.
引用
收藏
页码:442 / 448
页数:7
相关论文
共 50 条
  • [31] Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
    Ahn, Seung Woo
    Lee, Se Hee
    Kim, Uh Jin
    Jang, Hee-Chang
    Choi, Hak-Jong
    Choy, Hyon E.
    Kang, Seung Ji
    Roh, Seong Woon
    GUT PATHOGENS, 2021, 13 (01)
  • [32] Risk Factors of Patients With Diarrhea for Having Clostridioides (Clostridium) difficile Infection
    Lang, Vanessa
    Gunka, Katrin
    Ortlepp, Jan Rudolf
    Zimmermann, Ortrud
    Gross, Uwe
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [33] Gut microbiota in burned patients with Clostridioides difficile infection
    Shoaei, Parisa
    Shojaei, Hasan
    Siadat, Seyed Davar
    Moshiri, Arfa
    Vakili, Bahareh
    Yadegari, Sima
    Ataei, Behrooz
    Khorvash, Farzin
    BURNS, 2022, 48 (05) : 1120 - 1129
  • [34] Treatment of Clostridioides difficile Infection
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1632): : 137 - 141
  • [35] Retrospective Analysis of Clostridioides difficile Infection Rates and Outcomes in Hospitalized Patients during the COVID-19 Pandemic: A Unicenter Study in Reus, Spain
    Iftimie, Simona
    Lopez-Azcona, Ana F.
    Corchero-Valverde, Mireia
    Peralta-Vazquez, Antonio
    Lopez-Cordon, Laia Revuelta
    Garcia-Cervera, Carles
    Fernandez-Dominguez, Luis Manuel
    Camps, Jordi
    Joven, Jorge
    Castro, Antoni
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [36] Neutrophil Ratio of White Blood Cells as a Prognostic Predictor of Clostridioides difficile Infection
    Lee, Ching-Chi
    Lee, Jen-Chieh
    Chiu, Chun-Wei
    Tsai, Pei-Jane
    Ko, Wen-Chien
    Hung, Yuan-Pin
    JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 1943 - 1951
  • [37] Faecal microbiota transplantation for Clostridioides difficile infection
    Waldbaum, Carlos
    Lopez, Fabiana
    Antelo, Pablo
    Sorda, Juan
    MEDICINA-BUENOS AIRES, 2020, 80 (06) : 633 - 639
  • [38] A retrospective study investigating the management, risk factors, and outcomes of patients diagnosed with Clostridioides difficile infection
    Vongphakdi, Mitt M.
    Yui, Nicholas Ah
    Ocallaghan, Kevin
    JOURNAL OF PHARMACY PRACTICE AND RESEARCH, 2023, 53 (05) : 262 - 267
  • [39] Clostridioides difficile infection and recurrence in cancer patients (CIRCA): A multicentre, international study
    Puerta-Alcalde, Pedro
    O'Keefe, Jessica
    Woolstencroft, Rachel
    Kaul, Shipraa
    Lopez, Nestor
    Cronin, Katie
    Lim, Andrew
    Garcia-Pouton, Nicole
    Alvarez, Miriam
    Chee, Lynette
    Espasa, Mateu
    Grafia, Ignacio
    Suarez-Lledo, Maria
    Smibert, Olivia
    Garcia-Vidal, Carolina
    Slavin, Monica A.
    Yong, Michelle K.
    Soriano, Alex
    Worth, Leon J.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 153
  • [40] Antibiotic use and risk of Clostridioides difficile infection in patients with inflammatory bowel disease
    Bejcek, Alexis
    Ancha, Anupama
    Lewis, Megan
    Beaver, Ryan
    Tecson, Kristen
    Bomar, Jaccallene
    Johnson, Christopher
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (11) : 2417 - 2423